Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Janux Therapeutics (JANX) Leases (2021 - 2025)

Janux Therapeutics (JANX) has disclosed Leases for 5 consecutive years, with $18.4 million as the latest value for Q4 2025.

  • Quarterly Leases fell 4.58% to $18.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.4 million through Dec 2025, down 4.58% year-over-year, with the annual reading at $18.4 million for FY2025, 4.58% down from the prior year.
  • Leases for Q4 2025 was $18.4 million at Janux Therapeutics, down from $18.9 million in the prior quarter.
  • The five-year high for Leases was $22.8 million in Q2 2022, with the low at $130000.0 in Q1 2022.
  • Average Leases over 5 years is $17.1 million, with a median of $19.9 million recorded in 2024.
  • The sharpest move saw Leases surged 16766.92% in 2023, then dropped 8.04% in 2025.
  • Over 5 years, Leases stood at $185000.0 in 2021, then surged by 11942.7% to $22.3 million in 2022, then dropped by 6.47% to $20.8 million in 2023, then decreased by 7.45% to $19.3 million in 2024, then decreased by 4.58% to $18.4 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $18.4 million, $18.9 million, and $18.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.